Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...
Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...
Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.
U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...
Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer ...
US pharma group says region’s use of ‘one-way insurance system’ to keep down prices is not fair on the industry ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A ...
Weight loss drugs are set to become a disproportionate share of Lilly's business.